Nutritional and Therapeutic Strategies in Paediatric Phenylketonuria: A Narrative Literature Review
Nutrients · 24.04.2026 · 18 (9) · 1347
DOI: 10.3390/nu18091347 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 24.04.2026. Verfasst von Holly Jones und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Sunderland, Sunderland SR1 3SD, UK. Hauptthemen laut MEDLINE: Phenylketonurias, Phenylalanine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Phenylketonuria (PKU) is an autosomal recessive disorder characterised by an inborn error of phenylalanine (Phe) metabolism. Such errors are attributed to pathogenic gene variants causing phenylalanine hydroxylase (PAH) deficiency, impairing the hydroxylation of phenylalanine to tyrosine in the Phe metabolic pathway. This defect leads to plasma Phe concentrations above the normal range. If untreated, hyperphenylalaninemia can adversely affect brain function, leading to severe intellectual disability and seizures. Since 1969, the newborn dried blood spot test has remained the main method of early screening and diagnosis for PKU. The primary therapeutic management is a lifelong phenylalanine-restricted diet with the aim of decreasing plasma Phe levels. The recommended diet consists of avoiding high-protein foods such as meat, fish, eggs and nuts, and can be supplemented with high-protein medical formulas which are low in phenylalanine. Pharmacological interventions such as sapropterin, sepiapterin and pegvaliase can also be used as treatment adjuncts in patients with PKU. Currently, small-molecule inhibitors reducing renal phenylalanine reabsorption are being explored as a potential therapeutic intervention. Furthermore, novel gene-editing techniques are under evaluation as potential curative strategies, with preclinical studies showing promising results in correcting pathogenic phenylalanine hydroxylase variants. This non-systematic review synthesises current literature on the management of PKU, with a focus on dietary interventions and recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of Sunderland, Sunderland SR1 3SD, UK.
- The Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
ORCID-Profile: Eugen-Matthias Strehle
Zitieren
APA
Jones, H., & Strehle, E. M. (2026). Nutritional and Therapeutic Strategies in Paediatric Phenylketonuria: A Narrative Literature Review. Nutrients, 18(9), 1347. https://doi.org/10.3390/nu18091347
Vancouver
Jones H, Strehle EM. Nutritional and Therapeutic Strategies in Paediatric Phenylketonuria: A Narrative Literature Review. Nutrients. 2026;18(9):1347. doi:10.3390/nu18091347
BibTeX
@article{Jones2026,
author = {Jones, Holly and Strehle, Eugen-Matthias},
title = {Nutritional and Therapeutic Strategies in Paediatric Phenylketonuria: A Narrative Literature Review},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {9},
pages = {1347},
doi = {10.3390/nu18091347}
}
EUVIMED